PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-52

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,775 Posts.
    lightbulb Created with Sketch. 7032
    As expected, a nice shiny Power Point production showing positive bio-marker (and WOMAC) results. Cashed up and performing as many expected from past data. Thanks to the more informative contributors on here. Your hard work rightly rewarded with a decent share price rise. This stock should be trading at at least $1.80.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.